Sherbrooke, Canada

Jean-luc Ardilouze

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Eli Lilly and Company. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-luc Ardilouze. Retrieved from https://idiyas.com/inventor/jean-luc-ardilouze

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean-luc Ardilouze: Innovator in Pharmaceutical Preparations

Introduction

Jean-luc Ardilouze is a notable inventor based in Sherbrooke, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the area of insulin absorption and diabetes treatment. His innovative work has the potential to improve the lives of many individuals living with diabetes.

Latest Patents

Jean-luc Ardilouze holds a patent for a pharmaceutical preparation aimed at improving the absorption and postprandial hypoglycemic action of insulin. The patent describes compositions and combinations that include one or more insulin(s) and one or more vasoactive agent(s). This invention is designed to increase subcutaneous insulin absorption and to treat or prevent hyperglycemia and its complications in patients in need.

Career Highlights

Ardilouze is currently associated with Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly focuses on developing innovative solutions for diabetes management, showcasing his commitment to advancing healthcare.

Collaborations

Throughout his career, Jean-luc Ardilouze has collaborated with talented professionals, including Maude Gagnon-auger and Pascal Brassard. These collaborations have contributed to the development of effective pharmaceutical solutions.

Conclusion

Jean-luc Ardilouze is a distinguished inventor whose work in pharmaceutical preparations is paving the way for advancements in diabetes treatment. His innovative patent and collaborations reflect his dedication to improving patient care and outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…